Perspective · 10 Jan 2024
Conference abstract
Biosimilars: Lessons learned from development to commercial launch
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
I n this presentation I will discuss my experience launching of commercial biological and first biosimilar product from development to manufacturing to post marketing with special emphasis to building Quality by Design and Quality across the Product Lifecycle. I will discuss lessons learned from R & D (Clone Selection, Cell Bank Characterization, Expression and Yields), Technology Transfer to Product Development (up to pilot scale), and Analytical Development and specification set-up as per EP and validation of pilot batches, analytical and stability indicating methods. I will further discuss the pains of cross-functional teams and buy-ins from senior management, technical and marketing functions. Building a commercial launching group and collaborative executions to meet the timeline to launch the product. I will also discuss cost comparison manufacturing quality biosimilars in both highly regulated versus rest of the World. Is this strategy leading to successfully make Quality commercial batches of highly complex biological product (Upstream & Down Stream)? In this presentation, I will also discuss the role of Cross- functional teams, the management and suppliers. We will compare the cost & time for effective implementation of Quality by Design and building Quality across the product launch and life cycle management. PDF HTML
Keywords
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract · 4 Apr 2024
Understanding the commercial value of Biosimilars: Learning from launches in EU and US
Review article · 2020
The Development of Learning Management Process to Enhance the Competency of Student Teachers in Designing Instructional Package to Develop Creativity of Early Childhood by Using Problem-Based Learning and Lesson Study Approach
Other · 30 Jul 2016
Pioglitazone: lessons and learnings 15 years since launch and beyond
Conference abstract · 16 Sep 2020
Challenges With Successful Commercialization Of Biosimilars
More from this journal
The newest in Journal of Bioequivalence & Bioavailability.
Article · 5 Oct 2026
Long COVID in pediatric and young adult patients: a review of evaluation for microvascular changes, endothelial dysfunction, and arterial stiffness
Article · 12 Jun 2026
Advances in Bioavailability Through Innovative Drug Delivery Systems and Formulation Technologies
Article · 12 Jun 2026
Bioequivalence Study Design and Methodological Approaches in Generic Drug Evaluation
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Bioequivalence & Bioavailability
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Niranjan M. Kumar”
